These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 29503915)
61. Aftermarket effects of cenegermin for neurotrophic keratopathy in pediatric patients. Hatcher JB; Soifer M; Morales NG; Farooq AV; Perez VL; Shieh C Ocul Surf; 2021 Jul; 21():52-57. PubMed ID: 33887453 [TBL] [Abstract][Full Text] [Related]
62. [Current and experimental treatment approaches for neurotrophic keratopathy]. Alder J; Mertsch S; Menzel-Severing J; Geerling G Ophthalmologe; 2019 Feb; 116(2):127-137. PubMed ID: 30707284 [TBL] [Abstract][Full Text] [Related]
63. Maternal serum eye drops to treat bilateral neurotrophic keratopathy in congenital corneal anesthesia: Case report and literature review. Giannaccare G; Lucisano A; Pellegrini M; Scuteri G; Mancini A; Malaventura C; Busin M; Scorcia V Am J Ophthalmol Case Rep; 2022 Jun; 26():101446. PubMed ID: 35243177 [TBL] [Abstract][Full Text] [Related]
64. Associated Neurotrophic Keratopathy in Complex Regional Pain Syndrome. Soifer M; Gomez-Caraballo M; Venkateswaran N; Jay GW; Perez VL Cornea; 2021 Dec; 40(12):1600-1603. PubMed ID: 33591037 [TBL] [Abstract][Full Text] [Related]
65. A Novel Treatment for Neurotrophic Corneal Ulcer Using Topical Cenegermin (OXERVATE™) Containing Recombinant Human Nerve Growth Factor. Ahuja AS; Bowden FW; Robben JL Cureus; 2020 Nov; 12(11):e11724. PubMed ID: 33391953 [TBL] [Abstract][Full Text] [Related]
66. Resolution of a neurotrophic keratopathy associated hypopyon with cenegermin. Zambino N; Syed ZA Am J Ophthalmol Case Rep; 2021 Sep; 23():101113. PubMed ID: 34307960 [TBL] [Abstract][Full Text] [Related]
67. Neurotrophic keratopathy; its pathophysiology and treatment. Okada Y; Reinach PS; Kitano A; Shirai K; Kao WW; Saika S Histol Histopathol; 2010 Jun; 25(6):771-80. PubMed ID: 20376784 [TBL] [Abstract][Full Text] [Related]
68. Vitamin B12 Deficiency as a Cause of Neurotrophic Keratopathy. Nassiri N; Assarzadegan F; Shahriari M; Norouzi H; Kavousnezhad S; Nassiri N; Sheibani K Open Ophthalmol J; 2018; 12():7-11. PubMed ID: 29541277 [TBL] [Abstract][Full Text] [Related]
69. In Vivo and Ex Vivo Comprehensive Evaluation of Corneal Reinnervation in Eyes Neurotized With Contralateral Supratrochlear and Supraorbital Nerves. Giannaccare G; Bolognesi F; Biglioli F; Marchetti C; Mariani S; Weiss JS; Allevi F; Cazzola FE; Ponzin D; Lozza A; Bovone C; Scorcia V; Busin M; Campos EC Cornea; 2020 Feb; 39(2):210-214. PubMed ID: 31335523 [TBL] [Abstract][Full Text] [Related]
70. Neurotrophic keratopathy: Clinical presentation and effects of cenegermin. Bu JB; Gericke A; Pfeiffer N; Wasielica-Poslednik J Am J Ophthalmol Case Rep; 2022 Jun; 26():101488. PubMed ID: 35330588 [TBL] [Abstract][Full Text] [Related]
71. Functional and Structural Changes Following Corneal Neurotisation in the Management of Neurotrophic Keratopathy: UK Single Centre Series. Elalfy M; Maqsood S; Hau S; Kannan RY; Nduka C; Hamada S; Malhotra R Clin Ophthalmol; 2021; 15():2149-2160. PubMed ID: 34079213 [TBL] [Abstract][Full Text] [Related]
72. Direct Neurotization: Past, Present, and Future Considerations. Horen SR; Hamidian Jahromi A; Konofaos P Ann Plast Surg; 2022 Mar; 88(3):308-312. PubMed ID: 34611091 [TBL] [Abstract][Full Text] [Related]
73. REVERSIBLE NEUROTROPHIC KERATOPATHY ASSOCIATED WITH ROSUVASTATIN THERAPY: A CASE REPORT. Elnahry AG; Elnahry GA J Popul Ther Clin Pharmacol; 2019 Aug; 26(2):e38-e42. PubMed ID: 31577084 [TBL] [Abstract][Full Text] [Related]
74. In Vivo Evaluation of Corneal Nerves and Epithelial Healing After Treatment With Recombinant Nerve Growth Factor for Neurotrophic Keratopathy. Mastropasqua L; Lanzini M; Dua HS; D' Uffizi A; Di Nicola M; Calienno R; Bondì J; Said DG; Nubile M Am J Ophthalmol; 2020 Sep; 217():278-286. PubMed ID: 32387431 [TBL] [Abstract][Full Text] [Related]
76. Outcomes of corneal neurotisation using processed nerve allografts: a multicentre case series. Sweeney AR; Wang M; Weller CL; Burkat C; Kossler AL; Lee BW; Yen MT Br J Ophthalmol; 2022 Mar; 106(3):326-330. PubMed ID: 33199302 [TBL] [Abstract][Full Text] [Related]
77. Topical Recombinant Human Nerve Growth Factor (Cenegermin) for Neurotrophic Keratopathy: A Multicenter Randomized Vehicle-Controlled Pivotal Trial. Pflugfelder SC; Massaro-Giordano M; Perez VL; Hamrah P; Deng SX; Espandar L; Foster CS; Affeldt J; Seedor JA; Afshari NA; Chao W; Allegretti M; Mantelli F; Dana R Ophthalmology; 2020 Jan; 127(1):14-26. PubMed ID: 31585826 [TBL] [Abstract][Full Text] [Related]